ARK Genomic Revolution ETF Target of Unusually Large Options Trading (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the recipient of some unusual options trading activity on Thursday. Investors purchased 80,585 put options on the stock. This is an increase of approximately 731% compared to the typical daily volume of 9,696 put options.

Institutional Investors Weigh In On ARK Genomic Revolution ETF

Several institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets boosted its stake in shares of ARK Genomic Revolution ETF by 101.5% in the 1st quarter. BNP Paribas Financial Markets now owns 2,330,573 shares of the company’s stock valued at $67,027,000 after purchasing an additional 1,173,872 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of ARK Genomic Revolution ETF by 271.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock valued at $21,090,000 after purchasing an additional 469,740 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of ARK Genomic Revolution ETF by 835.6% in the 4th quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock valued at $6,990,000 after purchasing an additional 190,287 shares in the last quarter. Clearwater Capital Advisors LLC boosted its stake in shares of ARK Genomic Revolution ETF by 3.8% in the 1st quarter. Clearwater Capital Advisors LLC now owns 173,759 shares of the company’s stock valued at $4,997,000 after purchasing an additional 6,385 shares in the last quarter. Finally, Cetera Investment Advisers boosted its stake in shares of ARK Genomic Revolution ETF by 290.7% in the 1st quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock valued at $4,052,000 after purchasing an additional 104,831 shares in the last quarter.

ARK Genomic Revolution ETF Stock Performance

Shares of BATS:ARKG opened at $24.37 on Friday. The firm has a 50 day moving average price of $25.00 and a two-hundred day moving average price of $28.25.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.